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CASE REPORT e BLADDER RHABDOMYOSARCOMA
Eng-Kian Lim. Division of Urology, Putra Medical Centre, Alor Setar, Malaysia
Purpose: We reported a case of male bladder Rhabdomyosarcoma whom
received surgical intervention in our hospital.
Case Presentation: A 78 year old male of bladder tumor was noted and
treated in our hospital during 4th to 5th Nov, 2015. This 78 year old male
patient came to our urology outpatient department with chief complaints
of gross hematuria for few days. Lab data showed: mild anemia, hypona-
tremia, hyperglycemia (Hb: 11.5, Na: 131, Sugar: 25.4) with normal
Creatinine (Cr: 91). Abdomen sonography revealed: huge bladder tumor
lesion. He was admitted for cystoscopy and received TURBT on 4th, Nov
under spinal anesthesia without consequence. Meanwhile OHA (Metfor-
min) was given for DM control. Pathology revealed: Bladder Rhabdo-
myosarcoma. Post operation abdomen and pelvic CT scan was done with
no distant metastasis. He was then referred to government tertiary hos-
pital oncology department for further management.
Conclusion: Rhabdomyosarcoma is a malignant tumor (cancer) that arises
from a normal skeletal muscle cell. Rhabdomyosarcoma represents the
most common malignant soft tissue tumor in children and adolescents
with the urinary bladder representing a frequent site. Most of these are
embryonal Rhabdomyosarcoma, predominantly the botryoid subtype.
Rhabdomyosarcoma of bladder in adults are distinctively rare and only
case reports was noted. 1 The most commonmetastasis site are lung, bones
and bone marrow. Complete tumor excision should be considered for
localized adults cases as long as functional and cosmetic results are
acceptable. Radiotherapy is also a major tool for treatment, particularly
achieving local control in patients with residual microscopic or gross
disease following surgery and chemotherapy. 2
NDP044:
SMALL CELL CARCINOMA OF URINARY BLADDER e CASE REPORT AND
LITERATURE REVIEW
Jen-Hao Cheng, Kun-Yuan Chiu. Divisions of Urology, Department of Surgery,
Taichung Veterans General Hospital, Taichung, Taiwan
Small cell carcinoma of urinary bladder (SCCB) is very rare and accounting
for< 1% of all bladder tumors. Its has highly aggressive behavior and high
metastatic potential. We report a patient with SCCB managed by surgery
combined chemotherapy and we would provide a brief review of SCCB.
A 55-year-old woman was suffered from gross hematuria since May, 2015
and received transurethral resection of bladder tumor (TURBT) by local
medical doctor in Oct., 2015 and pathology report showed small cell car-
cinoma of urinary bladder without mention of depth of urinary bladder
invansion. She came to our hospital to received repeated TURBT and pa-
thology report showed small cell carcinoma combined with high grade
urothelial carcinoma with muscular layer (detrusor muscle) invasion.
Chest X-ray was normal and the abdominal CT revealed mass lesion about
25mm located over Lt lateral base with focal UB wall thickening. She
received neo-adjuvant chemotherapywithMethotrexate (MTX), Etoposide
(VP-16) and Cisplatin for three times. Then radical cystohysterectomy with
BPLND and ileal conduit reconstruction was performed and pathology
report showed residual small cell carcinoma invaded to deep muscularis
propria, lymph node invasions: 0/32, pathological TNM stage: ypT2bN0.
Patient recovered well and followed up at our hospital.
NDP045:
RENAL HEMANGIOBLASTOMA: AN UNUSUAL CASE
Cheng Chia-Wei, Tsai Yuh-Shyan. Department of Urology, National Cheng
Kung University Hospital, College of Medicine, Tainan, Taiwan
Renal hemangioblastoma is an uncommon tumor that can occur sporadi-
cally and viewed as a benign entity. Thus, we reported this tumor in a 47-
year-old Taiwanese male case, Hepatitis B virus carrier, whom was inci-
dentally found via abdominal computed tomography. There was no ﬂank
pain or hematuria complained. Abdominal sonography showed one
hyperechoic nodule (22mm) located at the upper pole of left kidney, mimicwith angiomyolipoma. Both of CT and MRI demonstrated moderate
enhancement. The RENAL score was 5.
Left retroperitoneal laparoscopic partial nephrectomy was performed
uneventfully with warm ischemia time of 12 minutes. Histologically, the
cellular portionwas composed of a rich capillary network of single-layered
ﬂat endothelial cells enclosing stromal cells, and the paucicellular portion
contained hyalinized stroma which are positive for alpha-inhibin and NSE
but negative for CK, CD68, CD34, HMB-45 and STAT-6. Although renal
hemangioblastoma is rare and difﬁcult to be diagnosed, it cannot be
neglected at all and required more cases for the further study.
NDP046:
CASE REPORT e FEMALE URETHRAL TUMOR
Eng-Kian Lim. Division of Urology, Putra Medical Centre, Alor Setar, Malaysia
Purpose: We reported 2 cases of female urethral tumor whom received
surgical intervention in our hospital.
Case Presentation: Two cases of female urethral tumor were noted and
treated in our hospital during Nov, 2014 to May, 2015. Case (1) was a 73
year old female patient with hypertension history. She visited our GYN and
Uro OPD on Nov, 2014 and was noted of her right simple ovary cyst
5 X 5 cm by sono and meatus urethral tumor around 1.5 cm. Urine test
disclosed: pyuria, proteinuria with microscopic hematuria (Bac: +, RBC:
5e10, WBC: 5e10, Pro: +). Lab data showed: anemia, hyponatremia, hy-
peruricemia, hyperlipidemia (Hb: 10.4, Na: 130, Uric acid: 383, cholesterol:
5.5). She received cystoscopy on 5/11/2014 and operation of excision of
urethral tumor on 18/11/2014 under SA without consequence. Pathology
revealed: benign urethral hemangioma. Case (2) was a 61 year old female
patient with diabetic and hypertension history. She visited our GYN and
Uro OPD on May, 2015 with complaints of vaginal protruding mass for 3
yrs. Further frequent urination and stress urinary incontinence were
complained. She was admitted under the impression of 3rd degree of
Uterine prolapse and meatus polypoid tumor. Urine test disclosed pyuria
with microscopic hematuria and (Bac:+, RBC: trace). Lab data was normal.
Kidney and bladder sono revealed negative. She received operation of
vaginal hysterectomy with ant., post. repair with meatus urethral tumor
excision on 24/5/2015 and was discharged on 25/5. The post operation
coursewas smooth. The pathological report revealed nonmalignant uterus
with meatus epithelial hyperplasia tumor.
Conclusion: Hemangioma is a relatively rare lesion in the genitourinary
tract. In general, hemangiomas are benign vascular tumor. Twenty cases
have been reported in literature. The lesion often extend further than is
immediately apparent. Endoscopic management is recommended for
small lesion and, in the case of more extensive lesions, open exploration is
advised followed by appropriate urethral reconstruction. 1 Further,
epithelial tumor represent approximately 80 % of all urinary tract tumors
(Bladder and urethral). They including TCC, SCC; adenoma; papilloma;
adenocarcinoma and undifferentiated carcinoma.2 We herein reported 2
cases of benign urethral tumor treated with open excisionmethod. Further
clinical follow up is advised.
NDP047:
BLADDER PARAGANGLIOMA: CASE REPORT
Yi-Chu Lin, Sheng-Han Tsai, Shin-Shu Chang. Department of Urology, Cheng
Hsin General Hospital, Taipei, Taiwan
Case Presentation: The 46 year-old man was found bladder tumor by
sonography during health examination, and he was referred to urology
outpatient department (OPD). According to the patient’s statement, he had
palpitation and headache during micturition in recent year, and hyper-
tension was diagnosed recently. Urine cytology was negative, abdominal
computed tomography (CT) showed a homogenous enhanced tumor about
3.5cm with lobulated contour between right posterior wall of urinary
bladder and sigmoid colon, cystoscopy showed an intramural bladder tu-
mor in posterior wall. According to the clinical symptoms and image
ﬁnding, rare bladder tumor was suspected, catecholamine was checked for
rule out paraganglioma and showed normal result. After discussion with
the patient, he decided received partial cystectomy. During operation,
systolic blood pressure would increase more than 180 mmHg when the
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monitor and careful control of blood pressure. The ﬁnal pathology report
was bladder paraganglioma, a rare bladder tumor.
Conclusion: Paragangliomas are rare neuroendocrine tumors that arise
from the extra-adrenal autonomic paraganglia, small organs consisting
mainly of neuroendocrine cells that are derived from the embryonic neural
crest and have the ability to secrete catecholamines. Sympathetic para-
gangliomas usually secrete catecholamines and are located in the sym-
pathetic paravertebral ganglia of thorax, abdomen, and pelvis. In contrast,
most parasympathetic paragangliomas are nonfunctional and located
along the glossopharyngeal and vagal nerves in the neck and at the base of
the skull. Catecholamine-secreting paragangliomas often present clinically
like pheochromocytomas with hypertension, episodic headache, sweating,
and tachycardia. In the genitourinary tract, the urinary bladder is the most
common site for paragangliomas. Bladder paraganglioma consisted only
0.05% of all bladder tumors. According to literature, bladder para-
ganglioma had similar characteristic as pheochromocytoma, but high
recurrence rated than pheochromocytoma, even with benign or small
tumors. Thus, if bladder paraganglioma was highly suspected, especially
with a large tumor size, partial or radical cystectomy with life-long follow-
up is strongly recommended.
LUTS
NDP048:
MIRABEGRON (25MG) IN PATIENTS WITH OVERACTIVE BLADDER IS
EFFECTIVE AND SAFE IN REAL LIFE PRACTICE
Yuan Chi Shen, Yao Chi Chuang. Division of Urology, Kaohsiung Chang Gung
Memorial Hospital and Chang Gung University College of Medicine, Taiwan
Purpose: Antimuscarinic (AM) agents are the mainstay of oral pharma-
cotherapy for overactive bladder (OAB), however, AM-associated adverse
events or insufﬁcient efﬁcacy limited its clinical persistence. Mirabegron is
a potent and selective b3-adrenoceptor agonist that could exert an
inhibitory effect on bladder afferent and OAB symptoms. We conducted a
postmarketing study to evaluate the efﬁcacy and safety of Mirabegron
(25mg) in patients with OAB.
Materials and Methods: The studywas a retrospective consecutive cohort
of 73OAB patients (50male and 23 female) treatedwithMirabegron 25mg.
The outcomes were initially assessed and re-evaluated 4 weeks later using
the uroﬂow study, post-void residual urine and questionnaire with Inter-
national Prostate Symptom Score (IPSS), Overactive Bladder Symptom
Score (OABSS), Urgency Severity Score (USS) and Quality of Life (QOL)
Results: At 4 weeks post-treatment, Mirabegron usage was associated
with a statistically signiﬁcant decrease in OABSS, USS, IPSS-V and IPSS-S
(Shown in Table.1). Furthermore, the nocturia scoring in IPSS questionnaire
was also decrease from 2.8± 1.7 to 2.2± 1.3 (p¼ 0.006). Table.2 showed no
compromise of uroﬂow rate and no increase of post-void residual urine.
Three out of 21 patients (14%) with hypertension was found with elevated
blood pressure, and discontinue Mirabegron treatment after one month of
initial treatment.
Conclusion: This post-marketing surveillance study conﬁrms that Mir-
abegron (25mg) improves clinical outcomes in patients with OAB and the
adverse effects was low.
NDP049:
THE RESULTS OF TRANSURETHRAL VAPORESECTION OF PROSTATE
USING THE REVOLIX LASER: CHI MEI HOSPITAL, LIOUYING
Eric W. Fan. Division of Urology, Department of Surgery, Chi Mei Medical
Center, Liouying, Taiwan
Purpose: Benign prostate hyperplasia (BPH) is a common disorder of men
over the age of ﬁfty. A number of laser based procedures have been
developed to treat the disorder. The potassium titanyl phosphate (KTP)
laser has to been used for vaporization of the prostate. The RevoLix 2
micron continuous wave Laser has been speciﬁcally designed to vaporize
and incise the prostate with good hemostasis.
Materials andMethods: This paper reviews the results of 217 patients that
were treated over a 12 month period with the new RevoLix Laser. The ageranged from 52 to 84 with a mean 67.2 years. The size of the prostate
ranged from 32.0 to 187.6 with a mean 68.2 grams. Prior to laser treatment
patients were examined, 47 patients had acute urine retention, 67 patients
had diabetes mellititus and 89 patients were on anticoagulants. Follow-up
was from 12 to 116 months. The RevoLix Laser was used at a power level
from 60 to 90 watts. An endﬁring 550 micron ﬁber was used with a
continuous ﬂow 26F cystoscope. VapoResection is a protocol whereby the
laser is used to resect and vaporize pieces of prostate similar the traditional
transurethral resection of prostate. Some pieces were ﬂushed out of the
bladder with the morcelation.
Results: All patients experienced 1 to 9 days of mild dysuria and mild
hematuria. 11 of 217 (5.1%) patients required catheterization in the ﬁrst
after treatment. The one year after transurethral VapoResection of Prostate
(TUVRP) the mean international prostatic symptom score (IPSS) decreased
from 23.2. to 11.8, the mean peak uroﬂow rate (UFR) increased from 7.5 to
16.2 mL/sec. Only one of 217 (0.4%) patients needed to check bleeding after
operation. 13 of 217 (6.0%) patients had urethral stricture or bladder neck
contracture 3e32 months later after TUVRP.
Conclusion: However, the results encourage to transurethral vapor-
esection of prostate using the RevoLix Laser for the treatment of BPH.
NDP050:
UROLOGICAL CONDITIONS WERE NOT RARE IN PATIENTS WITH
AMYOTROPHIC LATERAL SCLEROSIS
Tzu-Yu Chuang 1, Wei-Ming Cheng 1,2, Chang-Chi Chang 1,2, Yi-Chun
Chiu 1,2. 1Division of Urology, Department of Surgery, Zhongxiao Branch,
Taipei City Hospital, Taiwan; 2Department of Urology, School of Medicine,
National Yang-Ming University, Taipei, Taiwan
Purpose: Amyotrophic lateral sclerosis (ALS) is a progressive neurode-
generative disorders involving both upper and lower motor neurons. Pa-
tients with ALS would inevitably lose all somatic nerve function, but
autonomic nerve function is relatively preserved. Clinically we observed
that these patients might have variable lower urinary tract symptoms,
which hasn’t been reported in the medical literature. Therefore, we con-
ducted a retrospective observational study to investigate the prevalence of
urinary symptoms in one of the largest ALS referral centers in Taiwan.
Materials andMethods: We retrospectively reviewed patients with ALS in
our institute from January 1st 2014 to March 15th 2016. Those with urinary
symptoms that needed referral to a urologist were included. Age, sex,
comorbidities, initial presentation and duration of ALS, muscle power of
lower extremities, and urinalysis at the time of referral were obtained from
chart review or telephone interview. These data were analyzed with
descriptive statistics. Fisher’s exact test was used to compare possible
associated factors between ALS patients with urinary retention and those
without. P value less than 0.05 was viewed as statistical signiﬁcance.
Results: Sixteen patients have been included, accounting for 12.4% of all
ALS patients in our institute during the study period. Twelve were males
(75%) and four were females (25%). Median age at referral was 61 (39e 79)
years of age. Median duration of ALS was 5 (0.5 e 29) years. Three (18.8%)
patients had type 2 diabetes, and 15 (93.8%) patients needed respiratory
support. Five (41.7%) patients presented initially with dysarthria, while
seven (58.3%) patients were diagnosed with ALS due to weakness of ex-
tremities. Ten (62.5%) patients preserved some degree of muscle power at
the time of urological referral. Refractory lower urinary tract symptoms
were the chief complaints, including voiding symptom predominance in
six (37.5%), storage symptom predominance in four (25.0%), and dysuria in
six patients (37.5%). Pyuria was only presented in two patients with
dysuria. Nine patients were diagnosed with urinary retention after eval-
uation by urologists. Median postvoid residual urine amount was 820
(550e2100) ml. Factors including age, sex, disease duration, residual
muscle power, or initial presentations were failed to show associationwith
the development of urinary retention in patients with ALS.
Conclusion: Urinary symptoms, including voiding and storage symptoms,
as well as dysuriawere not rare in patients with ALS. Urinary retentionwas
the most common urological conditions, but associated factors were failed
to be identiﬁed in the present study. A prospective study recruiting more
patients with ALS would be helpful to predict the development of urinary
retention in this patient population.
